For instance, oxaliplatin was found to induce immunogenic apoptosis in HCC cells, as evidenced by increased secretion of ICD biomarkers (ATP and high-mobility group box 1 (HMGB1)) from dying cells (148). This evidence concerns the gene HMGB1 and hepatocellular carcinoma.